P065: A genome-first approach to germline CHEK2 cancer risk in the Geisinger and UK Biobank cohorts*

• Sun Young Kim,
• Mark Ramos,
• Jung Kim,
• Jeremy Haley,
• Shanker Rao,
• Uyenlinh Mirshahi,
• Barry Graubard,
• Hormuzd Katki,
• David Carey,
• Douglas Stewart

Affiliations

Sun Young Kim

National Cancer Institute, Rockville, MD, Johns Hopkins Medical Institute, Baltimore, MD

Mark Ramos

National Cancer Institute, Rockville, MD

Jung Kim

National Cancer Institute, Rockville, MD

Jeremy Haley

Geisinger, Danville, PA

Shanker Rao

Geisinger, Danville, PA

Uyenlinh Mirshahi

Geisinger, Danville, PA

Barry Graubard

National Cancer Institute, Rockville, MD

Hormuzd Katki

National Cancer Institute, Rockville, MD

David Carey

Geisinger, Danville, PA

Douglas Stewart

National Cancer Institute, Rockville, MD